Lanzhou Foci Pharmaceutical Co., Ltd.

30
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000019W4
CNY
9.07
0.06 (0.67%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
966.00
1,149.00
1,027.00
802.00
654.00
615.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
966.00
1,149.00
1,027.00
802.00
654.00
615.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
153.00
188.00
187.00
156.00
122.00
121.00
Operating Expenses
0.00
1.00
2.00
1.00
1.00
1.00
General and Administration Expenses
202.00
236.00
191.00
137.00
116.00
145.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
928.00
1,085.00
966.00
758.00
642.00
632.00
Operating Profit (PBDIT) excl Other Income
37.00
64.00
61.00
44.00
12.00
-16.00
Other Income
38.00
24.00
75.00
69.00
123.00
104.00
Operating Profit (PBDIT)
133.00
146.00
190.00
162.00
189.00
141.00
Interest
0.00
1.00
2.00
1.00
1.00
1.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
55.00
58.00
53.00
48.00
52.00
53.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
77.00
86.00
134.00
112.00
135.00
86.00
Provision for Tax
7.00
13.00
21.00
17.00
22.00
8.00
Profit After Tax
60.00
67.00
108.00
93.00
108.00
74.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.12
0.13
0.21
0.18
0.21
0.15
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -15.97% vs 11.86% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -41.47% vs 5.06% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -39.76% vs -27.93% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is -10.60% vs -38.16% in Dec 2023

Compare Profit and Loss Results of Lanzhou Foci Pharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
No of Months
12
12
Operating Income
966.00
0
966.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
966.00
0
966.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
0.00
0
0.00
0%
Power & Fuel Cost
0.00
0
0.00
0%
Employee Cost
153.00
0
153.00
0%
Operating Expenses
0.00
0
0.00
0%
General and Administration Expenses
202.00
0
202.00
0%
Selling and Distribution Expenses
0.00
0
0.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
928.00
0
928.00
0%
Operating Profit (PBDIT) excl Other Income
37.00
0.00
37.00
0%
Other Income
38.00
0
38.00
0%
Operating Profit (PBDIT)
133.00
0
133.00
0%
Interest
0.00
0
0.00
0%
Profit before Depriciation and Tax
0.00
0
0.00
0%
Depreciation
55.00
0
55.00
0%
Profit Before Taxation & Exceptional Items
0.00
0
0.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
77.00
0
77.00
0%
Provision for Tax
7.00
0
7.00
0%
Profit After Tax
60.00
0
60.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
0.00
0
0.00
0%
Profit Available for appropriations
0.00
0
0.00
0%
Appropriations
0.00
0
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.1176
0
0.12
0%
Profit And Loss - Net Sales
Net Sales 966.13 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -15.97% vs 11.86% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 37.66 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -41.47% vs 5.06% in Dec 2023

Profit And Loss - Interest
Interest 0.89 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -39.76% vs -27.93% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax 60.07 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -10.60% vs -38.16% in Dec 2023